News
Regeneron Pharmaceuticals gains FDA approval for Lynozyfic drug targeting multiple myeloma, with launch details and executive ...
5h
Vietnam Investment Review on MSNAkeso's first bispecific ADC enters clinical trials, advancing ‘IO+ADC’ 2.0 strategyHONG KONG, July 3, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") has announced the successful ...
A cancer immunotherapy may slow Parkinson’s disease by blocking the spread of harmful brain proteins, Johns Hopkins researchers found.
6h
ThePrint on MSNGovt ropes in innovators & startups to fight antimicrobial resistance. How the initiative will workCentre for Cellular and Molecular Platforms Thursday launched a ‘One Health AMR Challenge 2025’ in Bengaluru to support ...
Jacobio Pharma submits phase I/II IND application for its BET inhibitor, JAB-8263 to treat autoimmune diseases to CDE in China: Beijing, Shanghai Friday, July 4, 2025, 13:00 Hrs [ ...
Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...
Nipocalimab's FDA approval revolutionizes generalized myasthenia gravis treatment, offering rapid symptom relief and improved ...
Gammagard Liquid ERC is a ready-to-use formulation with low IgA content designed to ease administration burden by removing the need to reconstitute.
MariTide helped participants lose up to 20% of their body weight in a year-long trial. But it could be years before the new ...
The new vaccine committee appointed by Secretary Robert F. Kennedy Jr. took minimal action in its first meeting.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results